Abbott Laboratoriesvs.Labcorp
ABT vs LH · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Abbott Laboratories is about 7.4× larger than Labcorp by market cap; Labcorp trades at the lower P/E (26.1 vs 35.5); year to date, Labcorp leads (+35.3% vs −6.9%).
Supply-chain link: Abbott Laboratories supplies Labcorp.
Side by side
| ABT | LH | |
|---|---|---|
| Market cap | $193B | $26.2B |
| Price | $116.13 | $337.68 |
| Today | −0.5% | −0.5% |
| Return YTD | −6.9% | +35.3% |
| Return 1Y | −12.0% | +22.0% |
| P/E | 35.5 | 26.1 |
| P/S | 4.1 | 1.8 |
| P/B | 3.8 | 3.0 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Abbott LaboratoriesABT
In vitro diagnostics, medical devices that include the Libre glucose sensors, nutrition products and generic medicines: Abbott runs all four.
Full ABT profile →LabcorpLH
Samples from across the US end up in Labcorp's laboratories, which handle routine clinical testing alongside genomics and specialty assays. A contract research arm works for drug developers.
Full LH profile →More ABT & LH comparisons
Other head-to-heads in the Diagnostics segment.